vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and FITLIFE BRANDS, INC. (FTLF). Click either name above to swap in a different company.
Cronos Group Inc. is the larger business by last-quarter revenue ($44.5M vs $25.9M, roughly 1.7× FITLIFE BRANDS, INC.). FITLIFE BRANDS, INC. runs the higher net margin — 6.3% vs -4.1%, a 10.4% gap on every dollar of revenue. On growth, FITLIFE BRANDS, INC. posted the faster year-over-year revenue change (72.6% vs 47.0%). Cronos Group Inc. produced more free cash flow last quarter ($9.7M vs $239.0K). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs 25.1%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
FitLife Brands, Inc. is a health and wellness firm developing, marketing and distributing premium nutritional supplements, sports nutrition products and weight management solutions. It serves North American fitness enthusiasts, athletes and health-focused consumers via retail and e-commerce channels.
CRON vs FTLF — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $25.9M |
| Net Profit | $-1.8M | $1.6M |
| Gross Margin | 36.4% | 34.5% |
| Operating Margin | -16.8% | 8.8% |
| Net Margin | -4.1% | 6.3% |
| Revenue YoY | 47.0% | 72.6% |
| Net Profit YoY | -104.2% | -20.8% |
| EPS (diluted) | $-0.01 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.5M | $25.9M | ||
| Q3 25 | $36.3M | $23.5M | ||
| Q2 25 | $33.5M | $16.1M | ||
| Q1 25 | $32.3M | $15.9M | ||
| Q4 24 | $30.3M | $15.0M | ||
| Q3 24 | $34.3M | $16.0M | ||
| Q2 24 | $27.8M | $16.9M | ||
| Q1 24 | $25.3M | $16.5M |
| Q4 25 | $-1.8M | $1.6M | ||
| Q3 25 | $26.0M | $921.0K | ||
| Q2 25 | $-39.7M | $1.7M | ||
| Q1 25 | $6.1M | $2.0M | ||
| Q4 24 | $43.7M | $2.1M | ||
| Q3 24 | $8.3M | $2.1M | ||
| Q2 24 | $-8.8M | $2.6M | ||
| Q1 24 | $-2.2M | $2.2M |
| Q4 25 | 36.4% | 34.5% | ||
| Q3 25 | 50.4% | 37.2% | ||
| Q2 25 | 43.4% | 42.8% | ||
| Q1 25 | 42.6% | 43.1% | ||
| Q4 24 | 35.7% | 41.4% | ||
| Q3 24 | 10.5% | 43.8% | ||
| Q2 24 | 22.7% | 44.8% | ||
| Q1 24 | 17.7% | 44.0% |
| Q4 25 | -16.8% | 8.8% | ||
| Q3 25 | -1.4% | 9.9% | ||
| Q2 25 | -15.9% | 15.6% | ||
| Q1 25 | -12.6% | 18.6% | ||
| Q4 24 | -37.5% | 19.2% | ||
| Q3 24 | -98.2% | 19.9% | ||
| Q2 24 | -56.1% | 21.7% | ||
| Q1 24 | -63.1% | 20.4% |
| Q4 25 | -4.1% | 6.3% | ||
| Q3 25 | 71.4% | 3.9% | ||
| Q2 25 | -118.7% | 10.8% | ||
| Q1 25 | 19.0% | 12.7% | ||
| Q4 24 | 144.3% | 13.8% | ||
| Q3 24 | 24.4% | 13.3% | ||
| Q2 24 | -31.5% | 15.5% | ||
| Q1 24 | -8.9% | 13.1% |
| Q4 25 | $-0.01 | $0.16 | ||
| Q3 25 | $0.07 | $0.09 | ||
| Q2 25 | $-0.10 | $0.18 | ||
| Q1 25 | $0.02 | $0.20 | ||
| Q4 24 | $0.12 | $0.22 | ||
| Q3 24 | $0.02 | $0.21 | ||
| Q2 24 | $-0.02 | $0.27 | ||
| Q1 24 | $-0.01 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $43.6M |
| Total Assets | $1.2B | $106.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $831.8M | — | ||
| Q3 25 | $824.2M | — | ||
| Q2 25 | $834.4M | — | ||
| Q1 25 | $837.8M | — | ||
| Q4 24 | $858.8M | — | ||
| Q3 24 | $862.0M | — | ||
| Q2 24 | $848.2M | — | ||
| Q1 24 | $855.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $46.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $13.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $16.5M |
| Q4 25 | $1.1B | $43.6M | ||
| Q3 25 | $1.1B | $41.9M | ||
| Q2 25 | $1.1B | $40.9M | ||
| Q1 25 | $1.1B | $38.9M | ||
| Q4 24 | $1.1B | $36.1M | ||
| Q3 24 | $1.1B | $34.2M | ||
| Q2 24 | $1.1B | $31.9M | ||
| Q1 24 | $1.1B | $29.4M |
| Q4 25 | $1.2B | $106.3M | ||
| Q3 25 | $1.2B | $110.0M | ||
| Q2 25 | $1.2B | $62.8M | ||
| Q1 25 | $1.2B | $62.2M | ||
| Q4 24 | $1.2B | $58.5M | ||
| Q3 24 | $1.2B | $58.6M | ||
| Q2 24 | $1.1B | $57.3M | ||
| Q1 24 | $1.1B | $55.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.11× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.36× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.56× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $244.0K |
| Free Cash FlowOCF − Capex | $9.7M | $239.0K |
| FCF MarginFCF / Revenue | 21.8% | 0.9% |
| Capex IntensityCapex / Revenue | 4.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | 0.15× |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | $7.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $244.0K | ||
| Q3 25 | $13.3M | $3.7M | ||
| Q2 25 | $2.8M | $1.2M | ||
| Q1 25 | $-2.1M | $2.3M | ||
| Q4 24 | $7.7M | $957.0K | ||
| Q3 24 | $11.6M | $2.0M | ||
| Q2 24 | $1.7M | $1.6M | ||
| Q1 24 | $-2.2M | $5.0M |
| Q4 25 | $9.7M | $239.0K | ||
| Q3 25 | $8.8M | $3.7M | ||
| Q2 25 | $-1.0M | $1.2M | ||
| Q1 25 | $-17.4M | $2.3M | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $5.2M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | $-3.9M | $5.0M |
| Q4 25 | 21.8% | 0.9% | ||
| Q3 25 | 24.3% | 15.6% | ||
| Q2 25 | -3.0% | 7.4% | ||
| Q1 25 | -53.8% | 14.5% | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -15.5% | 30.4% |
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 12.3% | 0.0% | ||
| Q2 25 | 11.5% | 0.0% | ||
| Q1 25 | 47.3% | 0.2% | ||
| Q4 24 | 11.7% | 0.0% | ||
| Q3 24 | 18.7% | 0.0% | ||
| Q2 24 | 2.6% | 0.0% | ||
| Q1 24 | 6.8% | 0.1% |
| Q4 25 | — | 0.15× | ||
| Q3 25 | 0.51× | 3.99× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | -0.34× | 1.15× | ||
| Q4 24 | 0.18× | 0.46× | ||
| Q3 24 | 1.39× | 0.96× | ||
| Q2 24 | — | 0.60× | ||
| Q1 24 | — | 2.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
FTLF
Segment breakdown not available.
